• Molecular NameNaftidrofuryl
  • Synonymnafronyl; naftidrofuryl oxalate; nafronyl oxalate
  • Weight383.532
  • Drugbank_IDN/A
  • ACS_NO31329-57-4
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)5.52
  • pkaN/A
  • LogD (pH=7, predicted)3.76
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-2.73
  • LogSw (predicted, AB/LogsW2.0)0.01
  • Sw (mg/ml) (predicted, ACD/Labs)0.01
  • No.of HBond Donors0
  • No.of HBond Acceptors4
  • No.of Rotatable Bonds11
  • TPSA38.77
  • StatusN/A
  • AdministrationN/A
  • PharmacologyA drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic.
  • Absorption_value100.0
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A